Relevance of renin expression by real-time PCR in acute myeloid leukemia

References

• Hilden J M, Frestedt J L, Moore R O, Heerema N A, Arthur D C, Reaman G H, Kersey J H. Molecular analysis of infant acute lymphoblastic leukemia: MLL gene rearrangement and reverse transcriptase polymerase chain reaction for t(4;11)(q21;q23). Blood 1995; 86: 3876–3882
   PubMed Web of Science ®Google Scholar
• Nakao M, Yokota S, Horiike S, Taniwaki M, Kashima K, Sonoda Y, et al. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia. Leukemia 1996; 10: 1463–1470
   PubMed Web of Science ®Google Scholar
• Foroni L, Harrison C J, Hoffbrand A V, Potter M N. Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis. Br J Haematol 1999; 105: 7–24
   PubMed Web of Science ®Google Scholar
• Lo Coco F, Diverio D, Avvisati G, Petti M C, Meloni G, Pogliani E M, et al. Therapy of molecular relapse in acute promyelocytic leukemia. Blood 1999; 94: 2225–2229
   PubMed Web of Science ®Google Scholar
• Radich J, Thomson B. Advances in the detection of minimal residual disease. Current Opinions in Hematology 1997; 4: 242–247
   PubMedGoogle Scholar
• Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, et al. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 1994; 84: 3071–3079
   PubMed Web of Science ®Google Scholar
• Kreuzer K A, Saborowski A, Lupberger J, Appelt C, Na I K, le Coutre P, Schmidt C A. Fluorescent 5′-exonuclease assay for the absolute quantification for monitoring human leukaemias. Br J Haematol 2001; 114: 313–318
   PubMed Web of Science ®Google Scholar
• Alberta J, Springett G M, Rayburn H, Natoli T A, Loring J, Kreidberg J A, Housman D. Role of the WT1 tumor suppressor in murine hematopoiesis. Blood 2003; 101: 2570–2574
   PubMed Web of Science ®Google Scholar
• Chellappan S P, Hiebert S A, Mudryj M, Horowitz J M, Nevins J R. The E2F transcription factor is a cellular target for the Rb protein. Cell 1991; 65: 1053–1061
   PubMed Web of Science ®Google Scholar
• Sasaki O, Meguro K, Tohmiya Y, Funato T, Shibahara S, Sasaki T. Altered expression of retinoblastoma protein-interacting zinc finger gene, RIZ, in human leukaemia. Br J Haematol 2002; 119: 940–948
   PubMed Web of Science ®Google Scholar
• Gilliland D G, Griffin J D. The roles of FLT3 in hematopoiesis and leukemia. Blood 2002; 100: 1532–1542
   PubMed Web of Science ®Google Scholar
• Garg M, Moore H, Tobal K, Yin A L. Prognostic significance of quantitative analysis of WT1 gene transcripts by competitive reverse transcription polymerase chain reaction in acute leukaemia. Br J Haematol 2003; 123: 49–59
   PubMed Web of Science ®Google Scholar
• Gomez R A, Norling L L, Wilfong N, Isakson P, Lynch K R, Hock R, Quesenberry P. Leukocytes synthesize angiotensinogen. Hypertension 1993; 21: 470–475
   PubMed Web of Science ®Google Scholar
• Haznedaroglu I C, Tuncer S, Gürsoy M. A local renin–angiotensin system in the bone marrow. Medical Hypotheses 1996; 46: 507–510
   PubMed Web of Science ®Google Scholar
• Haznedaroglu I C, Buyukasik Y. Current evidence for the existence of a local renin–angiotensin system affecting physiological and pathological haematopoiesis in the bone marrow. Br J Haematol 1997; 99: 464–472
   PubMedGoogle Scholar
• Haznedaroglu I C, Öztürk M A. Towards the understanding of the local hematopoietic bone marrow renin–angiotensin system. Int J Biochem Cell Biol 2003; 35: 867–880
   PubMed Web of Science ®Google Scholar
• Huckle W R, Earp H S. Regulation of cell proliferation and growth by angiotensin II. Progress in Growth Factor Research 1994; 5: 177–194
   PubMedGoogle Scholar
• Okamura A, Raukugi H, Ohishi M, Yanagitani Y, Takiuchi S, Moriguchi K, et al. Upregulation of renin–angiotensin system during differentiation of monocytes to macrophages. J Hypertens 1999; 17: 537–545
   PubMed Web of Science ®Google Scholar
• Chisi J E, Wdzieczak-Bakala J, Thierry J, Briscoe C V, Riches A C. Captopril inhibits the proliferation of hematopoietic stem and progenitor cells in murine long-term bone marrow cultures. Stem Cells 1999; 17: 339–344
   PubMed Web of Science ®Google Scholar
• Rodgers K E, Xiong S, Steer R, di Zerega G S. Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells 2000; 18: 287–294
   PubMed Web of Science ®Google Scholar
• Rieger K J, Saenz-Servent N, Papet M P, Wdzieczak-Bakala J, Morgat J L, Thierry J, et al. Involvement of human plasma angiotensin I-converting enzyme in the degradation of the hemoregulatory peptide N-acetyl-Seryl-Aspartyl-Lysyl-Proline. Biochem J 1993; 296: 373–378
   PubMed Web of Science ®Google Scholar
• Robinson S, Lenfant M, Wdzieczak-Bakala J, Melville J, Riches A. The mechanism of action of the tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro (AcSDKP) in the control of haematopoietic stem cell. Cell Proliferation 1992; 25: 623–632
   PubMed Web of Science ®Google Scholar
• Cole J, Ertoy D, Lin H, Sutliff R L, Ezan E, Guyene T T, et al. Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice. J Clin Invest 2000; 106: 1391–1398
   PubMed Web of Science ®Google Scholar
• Comte L, Lorgeot V, Volkov L, Allegraud A, Aldigier J C, Praloran V. Effects of the angiotensin converting enzyme inhibitor enalapril on blood hematopoietic progenitors and Acetyl-Ser-Asp-Lys-Pro concentrations. Eur J Clin Invest 1997; 27: 788–790
   PubMed Web of Science ®Google Scholar
• Mrug M, Stopka T, Julian B A, Prchal J F, Prchal J T. Angiotensin II stimulates proliferation of normal early erythroid progenitors. J Clin Invest 1997; 100: 2310–2314
   PubMed Web of Science ®Google Scholar
• Wulf G G, Jahns-Streubel G, Strutz F, Basenau D, Hufner M, Buske C, et al. Paraneoplastic hypokalemia in acute myeloid leukemia: a case of renin activity in AML blast cells. Ann Hematol 1996; 73: 139–141
   PubMed Web of Science ®Google Scholar
• Wulf G G, Jahns-Streubel G, Nobiling R, Strutz F, Hemmerlein B, Hiddemann W, Wormann B. Renin in acute myeloid leukaemia blasts. Br J Haematol 1998; 100: 335–337
   PubMed Web of Science ®Google Scholar
• Abali H, Haznedaroglu I C, Goker H, Celik I, Ozatli D, Koray Z, Caglar M. Circulating and local bone marrow renin-angiotensin system in leukemic hematopoiesis: preliminary evidences. Hematology 2002; 7: 75–82
   PubMedGoogle Scholar
• Azizi M, Rousseau A, Ezan E, Guyene T T, Michelet S, Grognet J M, et al. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-Acetyl-Seryl-Aspartyl-Lysyl-Proline. J Clin Invest 1996; 97: 839–844
   PubMed Web of Science ®Google Scholar
• Michaud A, Williams T A, Chauvet M T, Corvol P. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I. Mol Pharmacol 1997; 51: 1070–1076
   PubMed Web of Science ®Google Scholar
• Gómez Casares M T, de la Iglesia S, Perera M M, Lemes A, Campo C, Gonzalez San Miguel J D, et al. Renin expression in hematological malignancies and its role in the regulation of hematopoiesis. Leukemia & Lymphoma 2002; 43: 2377–2381
   PubMed Web of Science ®Google Scholar
• French–American–British (FAB) Co-operative Group, Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D A, Gralnick H R, Sultan C. Proposals for the classification of the acute leukaemias. Br J Haematol 1976; 4: 451–458
   Google Scholar
• Vardiman J W, Harris N L, Brunning R D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292–2302
   PubMed Web of Science ®Google Scholar
• European Group for the Immunological Characterization of Leukemias, Bene M C, Castoldi G, Knapp W, Ludwig W D, Matutes E, Orfao A, van't Veer M B. Proposals for the immunological classification of acute leukemias. Leukemia 1995; 9: 1783–1786
   PubMed Web of Science ®Google Scholar
• Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Cilloni D, Gottardi E, De Micheli D, Serra A, Volpe G, Messa F, et al. Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients. Leukemia 2002; 16: 2115–2121
   PubMed Web of Science ®Google Scholar